Developer docs
API playgroundTry for free, no card

Search company profiles

SEQSTER

Full company profile

uuid00086wa

Namestring
SEQSTER
Legal namestring
Seqster PDM, Inc.
Websiteurl
seqster.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

SEQSTER is a patient-centric healthcare data operating system founded in 2016 and headquartered in San Diego, California. The company aggregates fragmented clinical, genomic, and patient-generated health data into longitudinal, AI-ready records through its five-product 1-Click platform: 1-Click Patient (patient-mediated EHR retrieval), 1-Click Records (automated EHR retrieval at enterprise scale), 1-Click DataLake (population discovery across 150M+ de-identified patients and 200,000+ clinicians), 1-Click Eligibility (AI-powered clinical trial patient screening), and 1-Click Sites (turnkey clinical site enablement). Supporting modules include 1-Click Data Refinery (CCDA/FHIR harmonization into AI-ready records) and CoRD (Connected Research & Development). The platform integrates with 20+ EHR systems using FHIR and CCDA standards, maintains FDA 21 CFR Part 11 compliance, HIPAA certification with AES-256 encryption, GDPR compliance, and TEFCA Individual Access Services provider status.

The company serves three primary customer segments: pharmaceutical and biotech sponsors (Novartis, Boehringer Ingelheim, Takeda, AbbVie, Eli Lilly, Genentech, Praxis Precision Medicines) using the platform across clinical operations, medical affairs, REMS, real-world evidence, and HEOR; contract research organizations including Syneos Health and UBC; and digital health platforms (Medable, Datavant, PatientsLikeMe). Revenue is generated through quote-based annual enterprise SaaS subscriptions with custom pricing based on customer scale and use case complexity. Go-to-market is exclusively direct enterprise field sales, with a Request a Demo conversion motion on the website and active presence at major life sciences conferences including BIO International, ISPOR, JPM Healthcare, and SCOPE. The company has raised $16 million in total funding since founding, operates with 101-250 employees, and is privately held under the legal entity Seqster PDM, Inc., incorporated in Delaware.

Short descriptiontext

SEQSTER is a healthcare data operating system that aggregates fragmented clinical, genomic, and patient-generated data into longitudinal, AI-ready records for pharmaceutical sponsors, CROs, and digital health companies across clinical trials and real-world evidence workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health data interoperability, clinical trial recruitment, real-world evidence, patient health records, EHR integration
Industry3 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACABAH
Record Locator Services (RLS) & Longitudinal Record Aggregation
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAHAI
Clinical & Claims Data Integration for Population Health (payer-provider data fusion)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
Product category
Clinical Data Interoperability Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Platform/SaaS Licensing
TypeSubscription Recurring
Description

SEQSTER generates revenue through licensing its patient-centric operating system platform to pharmaceutical companies, CROs, and healthcare organizations. The platform supports the full drug development lifecycle from clinical operations to medical affairs, REMS and patient services, and real-world evidence and HEOR. Revenue appears to come from subscription-based enterprise agreements with life sciences customers.

seqster.com
2Data Access and Query Services
TypeSubscription Recurring
Description

Revenue generated from providing access to the 1-Click DataLake platform for cohort discovery, feasibility analysis, and real-world evidence generation. Organizations pay for access to query longitudinal patient data across the 150M+ patient network for clinical trial design and recruitment purposes.

seqster.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise pricing - custom quote-based model for pharmaceutical sponsors, CROs, and healthcare organizations
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing tiers available. The company employs a direct sales approach with 'Request a Demo' CTAs indicating enterprise sales motion with custom pricing based on organizational needs and scale.

seqster.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
11-Click Patient™
Description

Patient-mediated EHR retrieval platform enabling patients to connect, collect and share data from any healthcare provider nationwide.

seqster.com
+4 more records
Core offering1 text field

SEQSTER provides a patient-centric operating system that connects, cleanses, and transforms longitudinal health data for life sciences and healthcare stakeholders. The platform aggregates clinical, genomic, and patient-generated data from over 20 EHR systems into unified records spanning 150M+ de-identified patients and 200,000+ clinicians. Its five core '1-Click' modules (Patient, Records, DataLake, Eligibility, Sites) plus the 1-Click Data Refinery harmonization engine and CoRD research platform are sold to pharmaceutical sponsors, CROs, and digital health companies to accelerate clinical trial recruitment, automate medical record retrieval, enable real-world evidence generation, and support AI-driven clinical research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Nearly 6 months acceleration in trial timelines achieved by screening 10,000+ patients and identifying eligible participants in under an hour
+4 more records
Product overview1 text field

SEQSTER is a patient-centric operating system and data connection, collection, and orchestration layer for patient health data. The platform connects, cleanses, and transforms longitudinal health data for stakeholders in life sciences and healthcare. The product portfolio consists of five core "1-Click" modules (Patient, Records, DataLake, Eligibility, and Sites) that work together as an integrated system: 1-Click Patient enables patient-mediated EHR retrieval, 1-Click Records provides automated EHR retrieval at enterprise scale, 1-Click DataLake enables population discovery and real-world evidence generation, 1-Click Eligibility powers AI-driven clinical trial patient screening, and 1-Click Sites transforms clinical sites into research-ready data collection points. Supporting modules include 1-Click Data Refinery for data harmonization and CoRD for connected research and development. The platform aggregates clinical, genomic, and patient-generated data in real time to create a complete longitudinal view of patient health.

Product and service7 records
11-Click Patient™
CategoryPatient-mediated EHR retrieval
Description

Patient-mediated EHR retrieval solution enabling patients to connect, collect, and share their health data from any healthcare provider nationwide through credential-based authentication with continuous updates as new clinical data becomes available. Designed for life sciences sponsors and healthcare organizations seeking patient-driven data access.

21-Click Records™
CategoryAutomated EHR retrieval
Description

Automated EHR retrieval platform connecting all health records nationwide with comprehensive longitudinal health data access, advanced cohort filtering, interactive visualization of patient journeys, and FDA 21 CFR Part 11 compliant workflows. Built for enterprise life sciences, healthcare, and research customers.

31-Click DataLake™
CategoryReal-world evidence and population discovery
Description

Population discovery and real-world evidence platform providing access to 150+ million de-identified patients with longitudinal health records, structured and unstructured clinical data, NPI data with national coverage, and AI-ready datasets for advanced analytics. Targets pharma sponsors, CROs, and researchers needing cohort discovery and feasibility analysis.

41-Click Eligibility™
CategoryAI-powered clinical trial eligibility screening
Description

AI-powered patient screening solution for clinical trials that identifies and prioritizes eligible participants in minutes using AI trained on high-quality longitudinal health data, with eligibility scoring based on data completeness, recency, and fit. Built for clinical operations teams running patient recruitment for pharmaceutical trials.

51-Click Sites™
CategoryClinical site activation and data collection
Description

Platform transforming clinical sites into research-ready data collection points with turnkey activation, no software installation or custom EHR integrations required, branded FDA 21 CFR Part 11-compliant study portals, and continuous data capture across the study lifecycle. Designed for sponsors, CROs, and site networks running decentralized clinical trials.

61-Click Data Refinery™
CategoryData harmonization engine
Description

Enterprise-grade data harmonization engine that transforms raw, patient-consented EHR data in CCDA and FHIR formats into clean, structured, AI-ready patient records by normalizing and deduplicating records across health systems and clinical notes. Targets pharma sponsors and CROs deploying AI in regulated clinical environments.

7CoRD™ (Connected Research & Development)
CategoryConnected research and development platform
Description

Platform accelerating drug discovery and deep insights for pharmaceutical companies by connecting patient data with research workflows to enable faster development and real-world evidence generation. Built for pharmaceutical R&D organizations.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership25 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-11
Description

Strategic partnership to improve sepsis detection by combining SEQSTER's real-time patient data platform with Clairyon's COMPOSER predictive AI model. Building on Clairyon's proven 17% relative reduction in sepsis mortality at UC San Diego Health, the partnership aims to scale nationally and potentially save an additional 50,000 lives by detecting sepsis earlier through real-time data access and predictive AI.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-28
Description

Technology partnership supporting MSIN (Multiple Sclerosis Implementation Network), a practice-based research network connecting MS care centers throughout the United States. SEQSTER enables data sharing and insights to improve care and outcomes for people living with multiple sclerosis, with the initiative expanding to over 1,000 participants across 20 sites nationwide.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-07
Description

Strategic partnership to help healthcare organizations access patient data across clinical settings as home healthcare and remote patient monitoring efforts expand. The partnership combines SEQSTER's unified data layer with Astute's secure infrastructure to ensure continuous data availability across care settings, enabling remote patient monitoring, care coordination, and AI-driven insights.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2026-04-16
Description

BioIVT, the leading provider of human biological products for drug discovery and development, is the first deployment partner for SEQSTER's 1-Click Sites platform. BioIVT will use the platform across its clinical sample collection network to provide richer longitudinal data for drug development decisions, enabling better tracking of lab results and clinical outcomes before and after treatment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-02
Description

Expanded multi-study collaboration to accelerate clinical trials, data collection, and real-world evidence generation across Praxis's clinical development programs for CNS disorders. Building on early success in Praxis's Essential3 Program for Essential Tremor, SEQSTER supports the broader ENERGY program advancing vormatrigine for epilepsy treatment, supporting approximately 5,000+ patients.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-03
Description

Strategic partnership combining SEQSTER's 1-Click Records with icometrix's AI-powered brain imaging technology (icobrain) to enhance detection, tracking, and management of neurological conditions including Alzheimer's Disease, Multiple Sclerosis, and Traumatic Brain Injury. The integration enables healthcare providers to track disease progression with greater precision.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-05
Description

Strategic partnership to power PatientsLikeMe's Connected Patient Health Hub with real-time EHR data. SEQSTER serves as the EHR provider enabling rapid and accurate patient screening for clinical trial opportunities while PatientsLikeMe provides patient engagement and health tracking platforms for condition-specific communities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-29
Description

Research partnership with Dr. Rhoda Au's team at Boston University Chobanian & Avedisian School of Medicine to develop an early-stage clinical screening tool for Alzheimer's disease using SEQSTER's 1-Click Records for longitudinal health data aggregation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-07-08
Description

Partnership to enhance patient identification and improve trial timelines and enrollment outcomes by leveraging SEQSTER's Operating System with Antidote's precision recruitment capabilities and best-in-class screening services.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-06-10
Description

Partnership to fast-track real world data collection for patients and researchers by combining SEQSTER's data unification capabilities with Thread's clinical trial platform.

11Audacity Health
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-12
Description

Partnership to accelerate clinical trial recruitment for pharma sponsors by combining SEQSTER's patient data platform with Audacity Health's recruitment expertise.

seqster.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-12-14
Description

Partnership to accelerate patient registries in clinical research, enabling health systems to save millions and accelerate evidence generation through integrated real-world data capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership enabling Takeda to extend its external data and digital collaboration ecosystem with better access to real-world evidence, integrating real-time data into workflows to generate powerful insights for research and patient services across 12 distinct use cases.

14Boehringer Ingelheim
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to close the Real World Evidence (RWE) gap through patient-centric data access with full consent and control. SEQSTER provides a ready-to-go solution delivering high fidelity and high quality data for Boehringer Ingelheim's evidence generation needs.

seqster.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner utilizing SEQSTER's platform for clinical operations and real-world evidence generation across drug development programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner participating in the Multiple Sclerosis Implementation Network (MSIN) research collaboration with SEQSTER and MSAA.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership where SEQSTER enables Syneos to access and utilize real-world data across clinical and commercial solutions. By automating the retrieval of longitudinal patient records, SEQSTER helps reduce administrative burden at investigative sites while supporting faster, more efficient patient identification and screening.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership integrating SEQSTER Admin Portal into UBC's pre-screening workflow to expedite acquisition of medical records, crucial for determining trial eligibility and capturing baseline eCRF data, enabling modernized study designs.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership integrating SEQSTER with Medable's decentralized clinical trial platform to provide clinicians with a more holistic view of patient health, leading to higher-quality trial results while simplifying the patient experience.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership enabling integration of real-world data into clinical trials to accelerate the clinical and commercial development process. SEQSTER's solution utilizes patient data captured in EHRs to fill important data gaps for sponsors working with Datavant.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership to study the impact of health data access on healthcare decisions, combining SEQSTER's data aggregation capabilities with Scripps' translational research expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Life sciences partner utilizing SEQSTER's platform for data integration and clinical research support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government health agency partner supporting SEQSTER's health data interoperability initiatives and TEFCA (Trusted Exchange Framework and Common Agreement) compliance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare data connectivity platform that links de-identified patient records across providers for clinical trials and real-world evidence. Directly overlaps with SEQSTER's 1-Click DataLake, 1-Click Records, and Data Refinery offerings, and is an active partner-ecosystem peer (founder Travis May publicly endorses SEQSTER).

TypeBroad incumbent
Description

Oncology-focused EHR data abstraction and real-world evidence platform owned by Roche. Competes with SEQSTER in oncology RWE and clinical-trial EHR aggregation, with deeper specialty focus but narrower therapeutic coverage than SEQSTER's horizontal platform.

TypeBroad incumbent
Description

Global clinical research services and real-world evidence leader. Overlaps with SEQSTER across CRO, RWE, and trial-recruitment services for pharma, but operates at vastly greater scale and breadth as a diversified incumbent.

4HealthVerity
TypeDirect peer
Description

Real-world data infrastructure and identity-resolution platform serving pharma, payers, and providers. Direct competitor to SEQSTER in patient-level data linkage, consent management, and HIPAA-compliant data exchange for clinical research.

TypeDirect peer
Description

Decentralized clinical trial platform partnering with SEQSTER for patient-mediated EHR data. Both companies target pharma/CRO trial digitization, with Medable focused on eCOA/telehealth and SEQSTER providing the longitudinal data layer underneath.

TypeBroad incumbent
Description

Major EHR and clinical data platform serving ambulatory providers. Competes with SEQSTER as an incumbent data source for life-sciences research via its FollowMyHealth and Research offerings, while also being a potential integration partner.

TypeDirect peer
Description

Real-world evidence and clinical informatics platform producing on-demand evidence from EHR data. Active SEQSTER integration partner for accelerating patient registries, and a direct competitor for pharma RWE budget.

8Tempus
TypeEmerging player
Description

AI-powered precision medicine platform combining clinical and molecular data for oncology. Overlaps with SEQSTER on AI-ready longitudinal patient records and pharma-grade datasets, though with a deeper genomics focus and broader therapeutic ambition.

TypeDirect peer
Description

Clinical trial recruitment and patient-matching platform. Active SEQSTER integration partner combining Antidote's screening capabilities with SEQSTER's longitudinal data, while also competing for the same trial-recruitment budget.

TypeEmerging player
Description

International patient-data network for clinical trial feasibility and real-world evidence across hospital systems. Comparable to SEQSTER's 1-Click DataLake but with broader European hospital coverage, serving as an indirect peer for global pharma sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SEQSTER

Clinical Data Interoperability Platformseqster.com

SEQSTER is a healthcare data operating system that aggregates fragmented clinical, genomic, and patient-generated data into longitudinal, AI-ready records for pharmaceutical sponsors, CROs, and digital health companies across clinical trials and real-world evidence workflows.

What SEQSTER does

SEQSTER is a patient-centric healthcare data operating system founded in 2016 and headquartered in San Diego, California. The company aggregates fragmented clinical, genomic, and patient-generated health data into longitudinal, AI-ready records through its five-product 1-Click platform: 1-Click Patient (patient-mediated EHR retrieval), 1-Click Records (automated EHR retrieval at enterprise scale), 1-Click DataLake (population discovery across 150M+ de-identified patients and 200,000+ clinicians), 1-Click Eligibility (AI-powered clinical trial patient screening), and 1-Click Sites (turnkey clinical site enablement). Supporting modules include 1-Click Data Refinery (CCDA/FHIR harmonization into AI-ready records) and CoRD (Connected Research & Development). The platform integrates with 20+ EHR systems using FHIR and CCDA standards, maintains FDA 21 CFR Part 11 compliance, HIPAA certification with AES-256 encryption, GDPR compliance, and TEFCA Individual Access Services provider status.

The company serves three primary customer segments: pharmaceutical and biotech sponsors (Novartis, Boehringer Ingelheim, Takeda, AbbVie, Eli Lilly, Genentech, Praxis Precision Medicines) using the platform across clinical operations, medical affairs, REMS, real-world evidence, and HEOR; contract research organizations including Syneos Health and UBC; and digital health platforms (Medable, Datavant, PatientsLikeMe). Revenue is generated through quote-based annual enterprise SaaS subscriptions with custom pricing based on customer scale and use case complexity. Go-to-market is exclusively direct enterprise field sales, with a Request a Demo conversion motion on the website and active presence at major life sciences conferences including BIO International, ISPOR, JPM Healthcare, and SCOPE. The company has raised $16 million in total funding since founding, operates with 101-250 employees, and is privately held under the legal entity Seqster PDM, Inc., incorporated in Delaware.

SEQSTER firmographics

Firmographics
Name
SEQSTER
Legal name
Seqster PDM, Inc.
Website
https://seqster.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
SEQSTER is a healthcare data operating system that aggregates fragmented clinical, genomic, and patient-generated data into longitudinal, AI-ready records for pharmaceutical sponsors, CROs, and digital health companies across clinical trials and real-world evidence workflows.
Ownership category
akta.pro rank

SEQSTER industry classification

Industry
Product category
Clinical Data Interoperability Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACABAH
Record Locator Services (RLS) & Longitudinal Record Aggregation
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAHAI
Clinical & Claims Data Integration for Population Health (payer-provider data fusion)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Health data interoperability
  • Clinical trial recruitment
  • Real-world evidence
  • Patient health records
  • EHR integration

Where SEQSTER is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SEQSTER business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform/SaaS Licensing: SEQSTER generates revenue through licensing its patient-centric operating system platform to pharmaceutical companies, CROs, and healthcare organizations. The platform supports the full drug development lifecycle from clinical operations to medical affairs, REMS and patient services, and real-world evidence and HEOR. Revenue appears to come from subscription-based enterprise agreements with life sciences customers.
  2. Data Access and Query Services: Revenue generated from providing access to the 1-Click DataLake platform for cohort discovery, feasibility analysis, and real-world evidence generation. Organizations pay for access to query longitudinal patient data across the 150M+ patient network for clinical trial design and recruitment purposes.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise pricing - custom quote-based model for pharmaceutical sponsors, CROs, and healthcare organizations

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

SEQSTER product offering

Product offering

Core offering

SEQSTER provides a patient-centric operating system that connects, cleanses, and transforms longitudinal health data for life sciences and healthcare stakeholders. The platform aggregates clinical, genomic, and patient-generated data from over 20 EHR systems into unified records spanning 150M+ de-identified patients and 200,000+ clinicians. Its five core '1-Click' modules (Patient, Records, DataLake, Eligibility, Sites) plus the 1-Click Data Refinery harmonization engine and CoRD research platform are sold to pharmaceutical sponsors, CROs, and digital health companies to accelerate clinical trial recruitment, automate medical record retrieval, enable real-world evidence generation, and support AI-driven clinical research.

Product overview

SEQSTER is a patient-centric operating system and data connection, collection, and orchestration layer for patient health data. The platform connects, cleanses, and transforms longitudinal health data for stakeholders in life sciences and healthcare. The product portfolio consists of five core "1-Click" modules (Patient, Records, DataLake, Eligibility, and Sites) that work together as an integrated system: 1-Click Patient enables patient-mediated EHR retrieval, 1-Click Records provides automated EHR retrieval at enterprise scale, 1-Click DataLake enables population discovery and real-world evidence generation, 1-Click Eligibility powers AI-driven clinical trial patient screening, and 1-Click Sites transforms clinical sites into research-ready data collection points. Supporting modules include 1-Click Data Refinery for data harmonization and CoRD for connected research and development. The platform aggregates clinical, genomic, and patient-generated data in real time to create a complete longitudinal view of patient health.

Differentiator

Problem solved

Functional benefit

Brands

  • 1-Click Patient™: Patient-mediated EHR retrieval platform enabling patients to connect, collect and share data from any healthcare provider nationwide.
  • 1-Click Records™
  • 1-Click DataLake™
  • 1-Click Eligibility™
  • 1-Click Sites™

Products and services

  • 1-Click Patient™ Patient-mediated EHR retrieval solution enabling patients to connect, collect, and share their health data from any healthcare provider nationwide through credential-based authentication with continuous updates as new clinical data becomes available. Designed for life sciences sponsors and healthcare organizations seeking patient-driven data access.
  • 1-Click Records™ Automated EHR retrieval platform connecting all health records nationwide with comprehensive longitudinal health data access, advanced cohort filtering, interactive visualization of patient journeys, and FDA 21 CFR Part 11 compliant workflows. Built for enterprise life sciences, healthcare, and research customers.
  • 1-Click DataLake™ Population discovery and real-world evidence platform providing access to 150+ million de-identified patients with longitudinal health records, structured and unstructured clinical data, NPI data with national coverage, and AI-ready datasets for advanced analytics. Targets pharma sponsors, CROs, and researchers needing cohort discovery and feasibility analysis.
  • 1-Click Eligibility™ AI-powered patient screening solution for clinical trials that identifies and prioritizes eligible participants in minutes using AI trained on high-quality longitudinal health data, with eligibility scoring based on data completeness, recency, and fit. Built for clinical operations teams running patient recruitment for pharmaceutical trials.
  • 1-Click Sites™ Platform transforming clinical sites into research-ready data collection points with turnkey activation, no software installation or custom EHR integrations required, branded FDA 21 CFR Part 11-compliant study portals, and continuous data capture across the study lifecycle. Designed for sponsors, CROs, and site networks running decentralized clinical trials.
  • 1-Click Data Refinery™ Enterprise-grade data harmonization engine that transforms raw, patient-consented EHR data in CCDA and FHIR formats into clean, structured, AI-ready patient records by normalizing and deduplicating records across health systems and clinical notes. Targets pharma sponsors and CROs deploying AI in regulated clinical environments.
  • CoRD™ (Connected Research & Development) Platform accelerating drug discovery and deep insights for pharmaceutical companies by connecting patient data with research workflows to enable faster development and real-world evidence generation. Built for pharmaceutical R&D organizations.

Quantifiable outcome

  • Nearly 6 months acceleration in trial timelines achieved by screening 10,000+ patients and identifying eligible participants in under an hour
  • +4 more outcomes

Companies that use SEQSTER

Customer profile

Named customers14 records

Segments4 records

Ideal customer profiles4 records

SEQSTER technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature6 records

SEQSTER partnerships and signals

Strategic signal

Partnerships

25 partnerships are on record, tiered core and flagship.

  • ClairyoncoreStrategic or Co-development Partner · 11 June 2026Strategic partnership to improve sepsis detection by combining SEQSTER's real-time patient data platform with Clairyon's COMPOSER predictive AI model. Building on Clairyon's proven 17% relative reduction in sepsis mortality at UC San Diego Health, the partnership aims to scale nationally and potentially save an additional 50,000 lives by detecting sepsis earlier through real-time data access and predictive AI.
  • Multiple Sclerosis Association of America (MSAA)coreStrategic or Co-development Partner · 28 May 2026Technology partnership supporting MSIN (Multiple Sclerosis Implementation Network), a practice-based research network connecting MS care centers throughout the United States. SEQSTER enables data sharing and insights to improve care and outcomes for people living with multiple sclerosis, with the initiative expanding to over 1,000 participants across 20 sites nationwide.
  • AstutecoreTechnology or Integration · 7 May 2026Strategic partnership to help healthcare organizations access patient data across clinical settings as home healthcare and remote patient monitoring efforts expand. The partnership combines SEQSTER's unified data layer with Astute's secure infrastructure to ensure continuous data availability across care settings, enabling remote patient monitoring, care coordination, and AI-driven insights.
  • BioIVTflagshipTechnology or Integration · 16 April 2026BioIVT, the leading provider of human biological products for drug discovery and development, is the first deployment partner for SEQSTER's 1-Click Sites platform. BioIVT will use the platform across its clinical sample collection network to provide richer longitudinal data for drug development decisions, enabling better tracking of lab results and clinical outcomes before and after treatment.
  • Praxis Precision MedicinescoreStrategic or Co-development Partner · 2 February 2026Expanded multi-study collaboration to accelerate clinical trials, data collection, and real-world evidence generation across Praxis's clinical development programs for CNS disorders. Building on early success in Praxis's Essential3 Program for Essential Tremor, SEQSTER supports the broader ENERGY program advancing vormatrigine for epilepsy treatment, supporting approximately 5,000+ patients.
  • icometrixcoreTechnology or Integration · 3 October 2024Strategic partnership combining SEQSTER's 1-Click Records with icometrix's AI-powered brain imaging technology (icobrain) to enhance detection, tracking, and management of neurological conditions including Alzheimer's Disease, Multiple Sclerosis, and Traumatic Brain Injury. The integration enables healthcare providers to track disease progression with greater precision.
  • PatientsLikeMecoreStrategic or Co-development Partner · 5 September 2024Strategic partnership to power PatientsLikeMe's Connected Patient Health Hub with real-time EHR data. SEQSTER serves as the EHR provider enabling rapid and accurate patient screening for clinical trial opportunities while PatientsLikeMe provides patient engagement and health tracking platforms for condition-specific communities.
  • Boston UniversitycoreStrategic or Co-development Partner · 29 July 2024Research partnership with Dr. Rhoda Au's team at Boston University Chobanian & Avedisian School of Medicine to develop an early-stage clinical screening tool for Alzheimer's disease using SEQSTER's 1-Click Records for longitudinal health data aggregation.
  • AntidotecoreTechnology or Integration · 8 July 2024Partnership to enhance patient identification and improve trial timelines and enrollment outcomes by leveraging SEQSTER's Operating System with Antidote's precision recruitment capabilities and best-in-class screening services.
  • ThreadcoreTechnology or Integration · 10 June 2024Partnership to fast-track real world data collection for patients and researchers by combining SEQSTER's data unification capabilities with Thread's clinical trial platform.
  • Audacity HealthcoreStrategic or Co-development Partner · 12 March 2024Partnership to accelerate clinical trial recruitment for pharma sponsors by combining SEQSTER's patient data platform with Audacity Health's recruitment expertise.
  • Atropos HealthcoreTechnology or Integration · 14 December 2023Partnership to accelerate patient registries in clinical research, enabling health systems to save millions and accelerate evidence generation through integrated real-world data capabilities.
  • TakedacoreStrategic or Co-development PartnerPartnership enabling Takeda to extend its external data and digital collaboration ecosystem with better access to real-world evidence, integrating real-time data into workflows to generate powerful insights for research and patient services across 12 distinct use cases.
  • Boehringer IngelheimcoreStrategic or Co-development PartnerPartnership to close the Real World Evidence (RWE) gap through patient-centric data access with full consent and control. SEQSTER provides a ready-to-go solution delivering high fidelity and high quality data for Boehringer Ingelheim's evidence generation needs.
  • NovartiscoreStrategic or Co-development PartnerPharmaceutical partner utilizing SEQSTER's platform for clinical operations and real-world evidence generation across drug development programs.
  • GenentechcoreStrategic or Co-development PartnerPharmaceutical partner participating in the Multiple Sclerosis Implementation Network (MSIN) research collaboration with SEQSTER and MSAA.
  • Syneos HealthcoreStrategic or Co-development PartnerPartnership where SEQSTER enables Syneos to access and utilize real-world data across clinical and commercial solutions. By automating the retrieval of longitudinal patient records, SEQSTER helps reduce administrative burden at investigative sites while supporting faster, more efficient patient identification and screening.
  • UBC (United BioSource)coreStrategic or Co-development PartnerPartnership integrating SEQSTER Admin Portal into UBC's pre-screening workflow to expedite acquisition of medical records, crucial for determining trial eligibility and capturing baseline eCRF data, enabling modernized study designs.
  • MedablecoreTechnology or IntegrationPartnership integrating SEQSTER with Medable's decentralized clinical trial platform to provide clinicians with a more holistic view of patient health, leading to higher-quality trial results while simplifying the patient experience.
  • DatavantcoreTechnology or IntegrationPartnership enabling integration of real-world data into clinical trials to accelerate the clinical and commercial development process. SEQSTER's solution utilizes patient data captured in EHRs to fill important data gaps for sponsors working with Datavant.
  • Scripps Research Translational InstitutecoreStrategic or Co-development PartnerResearch partnership to study the impact of health data access on healthcare decisions, combining SEQSTER's data aggregation capabilities with Scripps' translational research expertise.
  • AbbViecoreStrategic or Co-development PartnerPharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.
  • Eli LillycoreStrategic or Co-development PartnerPharmaceutical partner utilizing SEQSTER's platform for clinical data solutions.
  • Thermo Fisher ScientificcoreStrategic or Co-development PartnerLife sciences partner utilizing SEQSTER's platform for data integration and clinical research support.
  • Centers for Medicare and Medicaid ServicescoreStrategic or Co-development PartnerGovernment health agency partner supporting SEQSTER's health data interoperability initiatives and TEFCA (Trusted Exchange Framework and Common Agreement) compliance.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

SEQSTER competitors and assessment

Company assessment

Direct peers

  • Datavant: Healthcare data connectivity platform that links de-identified patient records across providers for clinical trials and real-world evidence. Directly overlaps with SEQSTER's 1-Click DataLake, 1-Click Records, and Data Refinery offerings, and is an active partner-ecosystem peer (founder Travis May publicly endorses SEQSTER).
  • HealthVerity: Real-world data infrastructure and identity-resolution platform serving pharma, payers, and providers. Direct competitor to SEQSTER in patient-level data linkage, consent management, and HIPAA-compliant data exchange for clinical research.
  • Medable: Decentralized clinical trial platform partnering with SEQSTER for patient-mediated EHR data. Both companies target pharma/CRO trial digitization, with Medable focused on eCOA/telehealth and SEQSTER providing the longitudinal data layer underneath.
  • Atropos Health: Real-world evidence and clinical informatics platform producing on-demand evidence from EHR data. Active SEQSTER integration partner for accelerating patient registries, and a direct competitor for pharma RWE budget.
  • Antidote: Clinical trial recruitment and patient-matching platform. Active SEQSTER integration partner combining Antidote's screening capabilities with SEQSTER's longitudinal data, while also competing for the same trial-recruitment budget.

Broad incumbents

  • Flatiron Health: Oncology-focused EHR data abstraction and real-world evidence platform owned by Roche. Competes with SEQSTER in oncology RWE and clinical-trial EHR aggregation, with deeper specialty focus but narrower therapeutic coverage than SEQSTER's horizontal platform.
  • IQVIA: Global clinical research services and real-world evidence leader. Overlaps with SEQSTER across CRO, RWE, and trial-recruitment services for pharma, but operates at vastly greater scale and breadth as a diversified incumbent.
  • Veradigm (formerly Allscripts): Major EHR and clinical data platform serving ambulatory providers. Competes with SEQSTER as an incumbent data source for life-sciences research via its FollowMyHealth and Research offerings, while also being a potential integration partner.

Emerging players

  • Tempus: AI-powered precision medicine platform combining clinical and molecular data for oncology. Overlaps with SEQSTER on AI-ready longitudinal patient records and pharma-grade datasets, though with a deeper genomics focus and broader therapeutic ambition.
  • Clinerion: International patient-data network for clinical trial feasibility and real-world evidence across hospital systems. Comparable to SEQSTER's 1-Click DataLake but with broader European hospital coverage, serving as an indirect peer for global pharma sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

SEQSTER social profiles

Digital presence

SEQSTER compliance and trust

Trust signal

Compliance3 records

SEQSTER financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SEQSTER leadership team

Management profile

Number of profiles

Profiles2 records

SEQSTER funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SEQSTER M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SEQSTER

What does SEQSTER do?

SEQSTER provides a patient-centric operating system that connects, cleanses, and transforms longitudinal health data for life sciences and healthcare stakeholders. The platform aggregates clinical, genomic, and patient-generated data from over 20 EHR systems into unified records spanning 150M+ de-identified patients and 200,000+ clinicians. Its five core '1-Click' modules (Patient, Records, DataLake, Eligibility, Sites) plus the 1-Click Data Refinery harmonization engine and CoRD research platform are sold to pharmaceutical sponsors, CROs, and digital health companies to accelerate clinical trial recruitment, automate medical record retrieval, enable real-world evidence generation, and support AI-driven clinical research.

Is SEQSTER a public or private company?

SEQSTER is a private company. It is classified as venture growth investor backed and is currently operating.

When was SEQSTER founded?

SEQSTER was founded in 2016. It employs 11 to 50 people.

Where is SEQSTER based?

SEQSTER is headquartered in San Diego, United States, in the North America region.

How does SEQSTER make money?

Two revenue lines are on record. Platform/SaaS Licensing is the primary driver. The others are data Access and Query Services.

Who are SEQSTER's main competitors?

Direct peers on record are Datavant, HealthVerity, Medable, Atropos Health and Antidote. Broad incumbents are Flatiron Health, IQVIA and Veradigm (formerly Allscripts). Emerging players are Tempus and Clinerion.

Does SEQSTER have an API?

No public API is recorded for SEQSTER.

What industry is SEQSTER in?

SEQSTER's product category is Clinical Data Interoperability Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACABAH, Record Locator Services (RLS) & Longitudinal Record Aggregation. Its NAICS code is 518210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FortuneHe fled war in Iran, became a millionaire, and built health tech that saved his dad from cancerThis Fortune profile article follows Ardy Arianpour, an Iranian refugee who became founder and CEO of Seqster, a health data platform with 150 million patient records that integrates with over 20 electronic health record systems. Arianpour previously scaled Ambry Genetics as senior vice president, leading its $1 billion acquisition by Konica Minolta before founding Seqster in 2016. The article, part of Fortune's 'Good Life' series on executive lifestyles, details his daily routines, spending habits, and personal philosophy alongside his professional journey and how Seqster's technology helped save his father's life during a cancer diagnosis.Business Wire BlogA Race Against Time: SEQSTER and Clairyon Partner to Catch Sepsis Earlier with Real-Time Data Access and Predictive AISEQSTER PDM, Inc. and Clairyon Inc. announced a strategic partnership to improve sepsis detection by combining SEQSTER's real-time patient data platform with Clairyon's COMPOSER predictive AI model, which has already demonstrated a 17% relative reduction in sepsis mortality at UC San Diego Health. The partnership aims to address the estimated 1.7 million sepsis cases and 350,000 annual deaths in the U.S., where each hour without treatment increases mortality by approximately 7%, with a goal of scaling nationally and potentially saving an additional 50,000 lives.Business Wire BlogSEQSTER Partners with Astute as At-Home Care and Remote Patient Monitoring Efforts Expand to Enable Secure, Data-Driven CareSEQSTER PDM Inc. announced a strategic partnership with Astute, Inc. to help healthcare organizations access patient data across clinical settings, addressing challenges of fragmented data and limited real-time access in home healthcare. The U.S. home healthcare market is expected to double over the next decade as care shifts beyond traditional hospital and clinic settings into the home. The partnership combines SEQSTER's unified data layer with Astute's infrastructure to ensure continuous data availability across care settings, enabling remote patient monitoring, care coordination, and AI-driven insights.YahooSEQSTER Partners with Astute as At-Home Care and Remote Patient Monitoring Efforts Expand to Enable Secure, Data-Driven CareSEQSTER PDM Inc. announced a strategic partnership with Astute, Inc. to help healthcare organizations access patient data across clinical settings, combining SEQSTER's unified data platform with Astute's secure infrastructure. The collaboration addresses persistent challenges in remote patient monitoring, including fragmented data across systems and limited real-time access, as the U.S. home healthcare market is expected to double over the next decade. The partnership enables continuous data availability across care settings, supporting use cases from remote patient monitoring and care coordination to clinical trial enrollment and real-world evidence generation.International Business TimesWhat Happens When Big Pharma Meets Big Tech?Eli Lilly unveiled its LillyPod supercomputer, built with 1,016 NVIDIA Blackwell Ultra GPUs, to accelerate drug discovery. The partnership highlights the convergence of pharma and tech, with governance frameworks like the EU AI Act and NIST standards addressing bias and accountability. The industry now requires bilingual talent bridging science and technology.Business Wire BlogSEQSTER Launches 1-Click Sites™ to Transform Clinical Sites into Research-Ready Data Collection Points: Names BioIVT as First Deployment PartnerSEQSTER PDM, Inc. launched "1-Click Sites," a new product enabling clinical sites to share patient-consented EHR data with trial sponsors without requiring software installation or health system contracts, eliminating months of traditional IT setup. The company announced a partnership with BioIVT, LLC as the first deployment partner, which will use the platform across its clinical sample collection network to provide richer longitudinal data for drug development decisions. The platform is designed to reduce activation timelines and expand the pool of research-ready locations for sponsors, CROs, and clinical networks.FierceHealthcareSeqster launches new data tool to turn clinical sites into 'research-ready data collection points'Seqster launched its 1-Click Sites platform with BioIVT as the first deployment partner, enabling clinical sites to share patient-consented electronic health record data with trial sponsors through FDA 21 CFR Part 11-compliant study portals. The platform reduces the time needed to set up clinical research data infrastructure from months to days by automating data aggregation, eligibility screening, and continuous monitoring. Founded in 2016, Seqster completed its five core products for healthcare and life sciences with this launch, aiming to turn clinical sites into research-ready data collection points and support drug discovery and development.HLTHSEQSTER Launches 1-Click Eligibility AI Tool to Accelerate Clinical Trial RecruitmentSEQSTER launched 1-Click Eligibility, an AI-powered tool designed to accelerate clinical trial patient recruitment by automating the identification of suitable candidates from large health data pools. The platform leverages consented longitudinal data from approximately 150 million patients to screen eligibility and rank candidates based on confidence scores. Early deployments with pharmaceutical partners have demonstrated the ability to reduce screening times significantly, potentially accelerating trial timelines.PharmiWeb.comSEQSTER Unveils AI-Powered Patient Screening for Clinical TrialsSEQSTER PDM, Inc. launched 1-Click Eligibility, an AI solution that identifies eligible clinical trial participants in minutes by analyzing longitudinal patient health data and matching it against trial criteria entered in everyday language. Early deployments have demonstrated significant impact, including one instance where the platform screened more than 10,000 patients and identified eligible participants in under an hour, enabling a research team to accelerate trial timelines by nearly six months. The launch addresses the persistent challenge in clinical trial recruitment, where nearly 80% of trials fail to meet enrollment timelines.